1252426

Mark S. LeDoux, M.D. — FEI 3031465210

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 30, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Memphis, TN (United States)

Additional Details

Clinical Investigator (CI)